Glimpse of PCD Pharma Companies in India Today
Pharma industry is one of the most flourishing and sought after industries in India ranking 3rd in the world in terms of volume and 14th in terms of value. The market is highly fragmented with more than 5,50,000 retail oulets. The number is significantly increasing every year. In terms of global market, the PCD pharma franchise industry in India holds around 1-2% share which is increasing at a fast rate of 10% every year.
The pharma industry has experienced a major paradigm shift in the past few years. The reason being the pharmaceutical firms in the past used to store the products in warehouses before distribution but in recent times, the Clearing and Forwarding agents (CFAs) have taken charge of the distribution. After the CFAs, the distribution passes on to the stockists who in turn make these products available to the pharmacies which eventually pass them to the consumers.
PCD pharma franchise in India operates under a gamut of policies which are mostly issued by the government and apply throughout the country. Some of these policies are:
Price Control- It contains the lists of the price controlled drugs, process of fixation of drug rates and penalties for contravention of the stipulated drug prices. These orders are meant to ensure that there is adequate supply of drugs and they are provided at a reasonable price. It also makes sure that the drug quality meets the required specifications, promotes rational use of drugs and strengthens the indigenous capability of drug production.
Intellectual Property Rights- It indicates the norms in respect to the following intellectual property rights:
- Geographical indications
- Protection of any undisclosed information about the product
Indian medicine franchise companies have started adapting to product development procedures and made their way in the international market by identifying the generic competitors to patent drugs and following up the necessary litigations to support the patent.
The pharmaceutical sector in India may be said to be uncertain and volatile but medicine franchise companies have risen up to the challenges put by measures like compulsory licensing, price controls and changing the FDI policy.